Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. VVCIF

Healthcare Drug Manufacturers - Specialty & Generic
VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

VIVO Cannabis Inc.
Bullboard Posts
User Avatar Image
(7)
•••
Comment by zen2twentyon Apr 04, 2019 5:00pm
115 Views
Post# 29584424

RE:Is Vivo going to be on that list?.....LOL

RE:Is Vivo going to be on that list?.....LOL
srtman03 wrote: Aphria, one of the selected in Germany for medical cannabis Aphria, Aurora and Demecan selected for German medical cannabis cultivation Published apr 4 19 / 2:25 pm | By Alfredo Pascual Three companies were chosen to cultivate medical marijuana in Germany the result of a long-delayed application process to provide product for one of the largest medical cannabis markets in the world. Canadas Aphria received five of the 13 lots that were up for grabs, according to Hendrik Knopp, managing director of Aphria Deutschland. The result is a very important footstep toward our twofold strategy of establishing a high-quality, in-country cultivation in Germany and importing additional flowers and oil from Canada and Denmark to provide the German market with complete cannabis medicine offering,



Wayland was selected.
It'll be interesting to see what their stock does tomorrow when the halt is lifted.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities